Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $473.5700 (-0.77%) ($472.7250 - $473.5700) on Fri. Mar. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.64% (three month average) | RSI | 56 | Latest Price | $473.5700(-0.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(36%) SPLV(36%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -0.82% in a week (0% probabilities). VIXM(-20%) UUP(-7%) VXX(-6%) TBT(-6%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.82% (StdDev 1.64%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $482.7(-1.89%) | 10 Day Moving Average | $476.23(-0.56%) | 20 Day Moving Average | $466.86(1.44%) | To recent high | -13.7% | To recent low | 6% | Market Cap | $50.212b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |